3[1]Rowinsk FK ,Cazenave LA,Donehower RC.Taxol:a nove investigational antimicrotubule agent.J Nail Cancer Inst ,1990(82):1247.
4[2]Brown T,Havlin k,Wesis Get al.A phase I trial of taxol given by 6-hour intravenous infusion.J Clin Oncol ,1991,9:1261.
5[3]Wiernik PH,Schwartz EK,Strauman JJ.Etal.Phase Icinical and pharmacikietic study of taxol.Cancer Res,1987,47:2486.
6[4]Rowinshy EK,Donehower RC.The clinical pharmacology of (taxol).Semin Oncol,1993,20(supp13):16.
7[11]解斌,戴振国.合理用药问答[M].第2版人民卫生出版社,1998.385
8Kim KB, Lotan R, Yue P, et al. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells[J]. Mol Cancer Ther, 2002, 1(3):177-184.
9Ma C, Lin H, Leonard SS, et al. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro[J]. Oncogene, 2003, 22(34):5281-5290.
10Alaoui-Jamali MA, Paterson J, Al Moustafa AE, et al. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications[J]. Biochem Cell Biol, 1997, 75(4): 315-325.
